Ensign Peak Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,180	Closed	-$58K	–	1931
2022 Q3	$58K	Buy	7,180 +4,500	+168%	+$36.4K	﹤0.01%	2194
2022 Q2	$19K	Hold	2,680	–	–	﹤0.01%	2129
2022 Q1	$41K	Buy	2,680 +470	+21%	+$7.19K	﹤0.01%	2145
2021 Q4	$48K	Buy	+2,210	New	+$48K	﹤0.01%	2144